Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60,660,421
-
Total 13F shares
-
24,050,108
-
Share change
-
+20,633,033
-
Total reported value
-
$357,352,000
-
Price per share
-
$14.86
-
Number of holders
-
40
-
Value change
-
+$306,574,000
-
Number of buys
-
39
Institutional Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q3 2021
As of 30 Sep 2021,
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,050,108 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Sands Capital Ventures, LLC, BlackRock Inc., Rock Springs Capital Management LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, Laurion Capital Management LP, GUARDIAN POINT CAPITAL, LP, and Woodline Partners LP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.